Price T Rowe Associates Inc Nuvation Bio Inc. Transaction History

Price T Rowe Associates Inc

$869 Billion
Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 215,267 shares of NUVB stock, worth $602,747. This represents 0.0% of its overall portfolio holdings.

Number of Shares

215,267

Previous 220,319 2.29%

Holding current value

$602,747

Previous $644,000 23.45%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$2.3 - $3.83 $11,619 - $19,349	-5,052 Reduced 2.29%	215,267 $493,000
Q2 2024 Aug 14, 2024	SELL	$2.58 - $3.69 $2.93 Million - $4.19 Million	-1,134,313 Reduced 83.74%	220,319 $644,000
Q1 2024 May 15, 2024	BUY	$1.46 - $3.97 $1.67 Million - $4.55 Million	1,146,794 Added 551.77%	1,354,632 $4.93 Million
Q4 2023 Feb 14, 2024	SELL	$0.96 - $1.53 $560,710 - $893,631	-584,073 Reduced 73.75%	207,838 $314,000
Q3 2023 Nov 14, 2023	SELL	$1.26 - $2.1 $17,524 - $29,206	-13,908 Reduced 1.73%	791,911 $1.06 Million
Q2 2023 Aug 14, 2023	SELL	$1.56 - $1.84 $76,202 - $89,880	-48,848 Reduced 5.72%	805,819 $1.45 Million
Q1 2023 May 15, 2023	SELL	$1.6 - $2.48 $32,272 - $50,021	-20,170 Reduced 2.31%	854,667 $1.42 Million
Q4 2022 Feb 14, 2023	SELL	$1.68 - $2.5 $61,649 - $91,740	-36,696 Reduced 4.03%	874,837 $1.68 Million
Q3 2022 Nov 14, 2022	BUY	$0.29 - $4.04 $239,663 - $3.34 Million	826,426 Added 971.04%	911,533 $2.04 Million
Q2 2022 Aug 15, 2022	BUY	$3.24 - $5.85 $112,275 - $202,720	34,653 Added 68.68%	85,107 $276,000
Q1 2022 May 16, 2022	BUY	$4.6 - $8.83 $60,775 - $116,661	13,212 Added 35.48%	50,454 $265,000
Q4 2021 Feb 14, 2022	BUY	$7.75 - $10.05 $179,536 - $232,818	23,166 Added 164.58%	37,242 $317,000
Q3 2021 Nov 15, 2021	BUY	$7.78 - $10.0 $20,173 - $25,930	2,593 Added 22.58%	14,076 $140,000
Q2 2021 Aug 16, 2021	BUY	$9.22 - $14.48 $105,873 - $166,273	11,483 New	11,483 $107,000

Others Institutions Holding NUVB

# of Institutions

159

Shares Held

157M

Call Options Held

3.2K

Put Options Held

98.7K

View Full List

About Nuvation Bio Inc.

Ticker NUVB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 217,244,000
Market Cap $608M
Description
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...

More about NUVB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Nuvation Bio Inc. Transaction History